List of Fusilev drug patents

Fusilev is owned by Acrotech.

Fusilev contains Levoleucovorin Calcium.

Fusilev has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Fusilev are:

  • US6500829

Fusilev was authorised for market use on 07 March, 2008.

Fusilev is available in solution;intravenous, powder;intravenous dosage forms.

The generics of Fusilev are possible to be released after 07 March, 2022.

FUSILEV Litigations
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6500829 ACROTECH Substantially pure diastereoisomers of tetrahydrofolate derivatives
Mar, 2022

(1 year, 15 days ago)

Drugs and Companies using LEVOLEUCOVORIN CALCIUM ingredient

Market Authorisation Date: 07 March, 2008

Treatment: NA


How can I launch a generic of FUSILEV before it's patent expiration?
More Information on Dosage

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in